Concepedia

Ann Gramza

AG

Statistics

Publications

2

Citations

34

H-Index

2

Active since

2022

Affiliations

Georgetown University(Current)

Ann Gramza is an author at Georgetown University specializing in oncology, pharmacology, and medicine.

Publications per year

2022–2023

2

Publications

2

A phase II study of tarloxotinib (a hypoxia activated prodrug of a pan-erb tyrosine kinase inhibitor) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or skin

Luke McLean, Tessa Altair Morris, Ann Gramza et al. · Investigational New Drugs · 2022 · 19 citations · Full text

, , +16

Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: a phase II, open-label, multicenter, multicohort study

Eric J. Sherman, J.L. Lee, Philip R. Debruyne et al. · ESMO Open · 2023 · 15 citations · Full text

, , +17

1–2 of 2